UW Med: Study of psilocybin with group therapy for patients with metastatic cancer

Tuesday, July 25, 2023

Psilocybin mushrooms photo courtesy GoodRx
Recruitment has begun for a small study of whether psilocybin, in the setting of group psychotherapy, can reduce anxiety related to a diagnosis of metastatic cancer.

Psilocybin is the psychedelic compound found in some species of mushrooms.

“Studies have explored psilocybin’s value among people with cancer, but in a format of two therapists to one patient. 
"Other researchers have seen impressive benefits of psilocybin in reducing anxiety and depression in a group setting. 
"I am asking the question of whether we could have a similar benefit for people with cancer in a group,” said Dr. Anthony Back, a UW Medicine oncologist and palliative-care specialist.

He will lead the study, which will include a maximum of 56 people and be based solely at the University of Washington School of Medicine. He expects to announce findings in about two years.

More details here.


Post a Comment

We encourage the thoughtful sharing of information and ideas. We expect comments to be civil and respectful, with no personal attacks or offensive language. We reserve the right to delete any comment.

Facebook: Shoreline Area News
Twitter: @ShorelineArea
Daily Email edition (don't forget to respond to the Follow.it email)

  © Blogger template The Professional Template II by Ourblogtemplates.com 2009

Back to TOP